Trial Profile
A Study on the Safety of Tranexamic Acid for the Chronic Subdural Hematoma Population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Nov 2021
Price :
$35
*
At a glance
- Drugs Tranexamic acid (Primary)
- Indications Subdural haematoma
- Focus Adverse reactions
- Acronyms TXA in CSDH
- 11 Oct 2021 Status changed from recruiting to completed.
- 15 Dec 2016 New trial record